The current study, an extension of the National Institutes of Health-funded Glucosamine/chondroitin Arthritis Intervention Trial (GAIT), did not measure effectiveness as a pain reliever, but specifically at impacts on disease progression. [...]
|
|||||||
|
The current study, an extension of the National Institutes of Health-funded Glucosamine/chondroitin Arthritis Intervention Trial (GAIT), did not measure effectiveness as a pain reliever, but specifically at impacts on disease progression. [...] |
|||||||
|
Copyright © 2012 Current Arthritis News and Research - All Rights Reserved
|
|||||||